Addus HomeCare Corporation
NASDAQ:ADUSMedical - Care Facilities
+$0.29 today
- Market cap
- $2.25B
- Beta
- 0.90
- P/E (TTM)
- 17.4
- EPS (TTM)
- $5.40
Volume 0.23M
Average 0.25M
ADUS Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Addus HomeCare CorporationNASDAQ: ADUS
Depreciation & Amortization · Q2 FY2026 · quarter ended Jun 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q2 FY2026 depreciation & amortization of $4.13M rose 5.4% year over year, behind the +15.1% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 2.4% from the prior quarter. Over 3 fiscal years it compounded at +5.3% a year.
Context
- Depreciation & amortization amounted to 1.2% of revenue in FY2025, unchanged from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +5.4% toward the trailing-twelve-month pace of +15.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 16.41M USD
- Year-over-year change
- +21.3%
- 4-year CAGR
- +3.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.41M | +21.3% |
| FY2024 | 2024-12-31 | 13.53M | -4.2% |
| FY2023 | 2023-12-31 | 14.13M | +0.5% |
| FY2022 | 2022-12-31 | 14.06M | -3.0% |
| FY2021 | 2021-12-31 | 14.49M | — |
Depreciation & Amortization vs competitors
How ADUS compares with its peers on the latest reported figures
- ADUS's LTM Jun 2026 depreciation & amortization of $16.71M is the 6th largest of the 7 companies compared; the peer median is $57.78M.
- Its year-over-year change of +15.1% is the 3rd highest of 7, against a peer median of +10.0%.
- Depreciation & amortization amounts to 1.1% of revenue for ADUS, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $346.5M | +9.8% | +10.4% | 5.6% | |
| LTM Jun 2026 | $114.56M | +21.9% | +18.7% | 2.1% | |
| LTM Jun 2026 | $66.42M | +4.1% | +3.1% | 2.6% | |
| LTM Sep 2026 | $49.13M | +10.2% | +3.5% | 3.1% | |
| LTM Oct 2026 | $30.08M | +6.5% | -10.1% | 1.1% | |
| LTM Jun 2026 | $16.71M | +15.1% | +5.3% | 1.1% | |
| LTM Mar 2026 | $12.91M | +93.3% | +20.3% | 1.3% | |
| Peer median (excluding ADUS) | $57.78M | +10.0% | +7.0% | 2.3% | |
Competitors are the stored peer set for ADUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 45.13M | 46.03M | 62.52M | 73.6M | 95.91M |
| Depreciation & Amortization | 14.49M | 14.06M | 14.13M | 13.53M | 16.41M |
| Deferred Income Tax | 7.28M | 3.91M | 2.82M | 13.19M | 17.87M |
| Stock-Based Compensation | 9.43M | 10.63M | 10.32M | 11.17M | 16.42M |
| Change in Working Capital | (38.61M) | 27.78M | 20.89M | 1.51M | (37.98M) |
| Accounts Receivables | (3.92M) | 20.59M | 15.67M | 22.14M | (26.65M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (4.81M) | 2.51M | 2.03M | (1.91M) | (12.66M) |
| Other Working Capital | (29.89M) | 4.67M | 3.2M | (18.72M) | 1.32M |
| Other Non-Cash Items | 1.77M | 2.71M | 1.58M | 3.44M | 2.88M |
| Operating Cash Flow | 39.49M | 105.11M | 112.25M | 116.43M | 111.51M |
| Capital Expenditures | (4.65M) | (8.3M) | (9.45M) | (6.05M) | (7.72M) |
| Acquisitions (Net) | (37.37M) | (98.29M) | (109.8M) | (348.59M) | (24.8M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 15K | 29K | 15K |
| Investing Cash Flow | (42.02M) | (106.59M) | (119.24M) | (354.61M) | (32.5M) |
| Debt Repayment | 28.27M | (90M) | (8.5M) | 96.65M | (98.67M) |
| Common Stock Issued | 1.11M | 2.55M | 319K | 179.04M | 2.48M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.03M) | 0 | 0 | (3.39M) | (113K) |
| Financing Cash Flow | 26.34M | (87.45M) | (8.18M) | 272.3M | (96.3M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 23.82M | (88.93M) | (15.17M) | 34.12M | (17.29M) |
| Free Cash Flow | 34.84M | 96.81M | 102.79M | 110.38M | 103.79M |
Addus HomeCare Corporation
NASDAQ:ADUS
Intrinsic Alpha fair value
Locked
Current Price
$120.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.